PSCs with IL-17RB overexpression increased mitochondrial respiration and decreased glycolysis in pancreatic cancer cells, possibly acting as a modifier of cancer cell metabolism (Li et al., 2021c). Here, IL17RB is linked to pancreatic neoplasm.